AstraZeneca PLC is 57.7x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($286.27 B vs $4.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | XENE | AZN |
|---|---|---|
| Market cap | $4.96 B | $286.27 B |
| US-listed rank | #1390 | #45 |
| Revenue (latest FY) | $311.00K | - |
| Net income (latest FY) | -$345.91M | - |
| Net margin | -111225.1% | - |
| SEC filings | 763 | 1,004 |
AstraZeneca PLC is 57.7x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($286.27 B vs $4.96 B).
Full pages: Xenon Pharmaceuticals Inc. and AstraZeneca PLC, or browse the full rankings.